Ignite Creation Date:
2024-05-05 @ 10:12 PM
Last Modification Date:
2024-10-26 @ 10:15 AM
Study NCT ID:
NCT01051388
Status:
COMPLETED
Last Update Posted:
2011-04-04
First Post:
2010-01-15
Brief Title:
Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
Sponsor:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Organization:
Translational Research Center for Medical Innovation Kobe Hyogo Japan
Study Overview
Official Title:
Prophylactic Efficacy of Proton Pump Inhibitor on Recurrence of Peptic Ulcer in Patients Continuously Treated With Low-dose Aspirin-Randomized Multi-center Single-blinded Parallel-group Comparative Study
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CARE
Brief Summary:
The aim of this study is to evaluate the efficacy of proton pump inhibitor PPI comparing to the mucosal defensive drug in the prevention of the recurrence of gastric andor duodenal ulcers during 12 weeks observation in patients receiving low-dose aspirin for vascular protection
Detailed Description:
The events of recurrence of gastric andor duodenal ulcers will be evaluated due to a blinded manner by specialized endoscopists at pre- and post administration during 12 weeks administration of PPI Rabeprazole sodium 10 mg or 20 mg tablet once a day or the mucosal defensive drug Gefarnate 50mg Capsule twice a day
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| UMIN000002901 | OTHER | Japan Infrastructure for Academic Activities University hospital Medical Information Network | None |